Clinical Trials Directory

Trials / Completed

CompletedNCT03492892

Use of Metabolomics to Differentiate the Antihypertensive Effect of Acupuncture From Sham Acupuncture in Hypertensives

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

To assess the effect of acupuncture versus sham acupuncture on regulating the targeted metabolome of hypertensive patients.

Detailed description

Acupuncture has been widely used for blood pressure management. Its effect on the cardiovascular-related targeted metabolome is still unknown. This pilot study aimed to assess the effect of acupuncture versus sham acupuncture on regulating the targeted metabolome of hypertensive patients.

Conditions

Interventions

TypeNameDescription
DEVICEAcupunctureStimulate acupoint with filiform needles to restore the healthy condition of patients
DEVICESham AcupunctureStimulate non-acupoint with filiform needles to treat the condition of patients

Timeline

Start date
2012-01-01
Primary completion
2016-08-19
Completion
2016-12-31
First posted
2018-04-10
Last updated
2018-04-13

Source: ClinicalTrials.gov record NCT03492892. Inclusion in this directory is not an endorsement.

Use of Metabolomics to Differentiate the Antihypertensive Effect of Acupuncture From Sham Acupuncture in Hypertensives (NCT03492892) · Clinical Trials Directory